AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 196 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $312,000 | -23.0% | 33,200 | -37.2% | 0.00% | -20.0% |
| Q2 2020 | $405,000 | +5.7% | 52,900 | -14.7% | 0.01% | 0.0% |
| Q1 2020 | $383,000 | -49.3% | 62,000 | 0.0% | 0.01% | -37.5% |
| Q4 2019 | $755,000 | -22.9% | 62,000 | -26.9% | 0.01% | -27.3% |
| Q3 2019 | $979,000 | +21.9% | 84,800 | +5.5% | 0.01% | +22.2% |
| Q2 2019 | $803,000 | -32.0% | 80,400 | +25.6% | 0.01% | -35.7% |
| Q3 2017 | $1,181,000 | -18.2% | 64,000 | -18.4% | 0.01% | -22.2% |
| Q2 2017 | $1,443,000 | +76.2% | 78,400 | +116.0% | 0.02% | +63.6% |
| Q1 2017 | $819,000 | +41.7% | 36,300 | +118.7% | 0.01% | +37.5% |
| Q4 2016 | $578,000 | +10.7% | 16,600 | -22.1% | 0.01% | 0.0% |
| Q3 2016 | $522,000 | +22.5% | 21,300 | +19.7% | 0.01% | +33.3% |
| Q2 2016 | $426,000 | -17.9% | 17,800 | +3.5% | 0.01% | -25.0% |
| Q4 2015 | $519,000 | +10.7% | 17,200 | +45.8% | 0.01% | +14.3% |
| Q3 2015 | $469,000 | -19.1% | 11,800 | +40.5% | 0.01% | -22.2% |
| Q2 2015 | $580,000 | +6.0% | 8,400 | -16.0% | 0.01% | +12.5% |
| Q1 2015 | $547,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |